8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period
globenewswire.com
news
2022-06-01 02:00:00

Singapore, May 31, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp.Â (the 'Company' or 'LAX') (NASDAQ: LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited, a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, today announced an amendment to the SPA (the 'SPA Amendment') to extend the time for LAX to complete its financial, operational and legal due diligence review of EUDA Health from May 31, 2022 to June 15, 2022.
